Cioffi G, Cemin C, Russo T E, Pellegrini A, Terrasi F, Ferrario G
Department of Cardiology, Villa Bianca Hospital, Italy.
Ital Heart J. 2000 Oct;1(10):691-7.
Atrial fibrillation (AF) is the most frequent complication following cardiac surgery. It occurs mostly between the second and fourth postoperative days and often recurs within 30 days after surgery. While postoperative AF has been well analyzed, post-discharge recurrences of AF have not been clearly described even if they are reported as a frequent cause of re-hospitalization.
We followed up 185 patients for 10 +/- 5 months with the aim of characterizing the post-discharge recurrences of AF. All patients had recently undergone cardiac surgery complicated by AF and were in sinus rhythm at the time of admission to our Center. We also compared the efficacy of the main prophylactic regimens adopted in the referral Centers (amiodarone, beta-blockers, amiodarone plus beta-blockers) during the first postoperative month.
In the first postoperative month AF recurred after discharge in 60 patients. The event rate was not different in patients treated with amiodarone and controls (47 vs 50%, p = NS), while it was significantly lower in patients taking beta-blockers either alone or associated with amiodarone (10 and 9% respectively, p = 0.002). At the end of follow up (10 +/- 5 months), AF persisted in 3 out of 176 study patients (1.7%).
In patients undergoing cardiac surgery, post-discharge recurrences of AF are frequent during the first postoperative month and have a clinical relevance. Beta-blockers (not amiodarone) seem to be an effective prophylactic measure. The phenomenon tends to vanish in the long term, and a chronic prophylaxis is not justified.
心房颤动(AF)是心脏手术后最常见的并发症。它大多发生在术后第二至四天之间,且常在术后30天内复发。虽然术后房颤已得到充分分析,但即使出院后房颤复发被报告为再次住院的常见原因,其情况仍未得到清晰描述。
我们对185例患者进行了10±5个月的随访,旨在明确出院后房颤复发的特征。所有患者近期均接受了并发房颤的心脏手术,且入院时处于窦性心律。我们还比较了各转诊中心在术后第一个月采用的主要预防方案(胺碘酮、β受体阻滞剂、胺碘酮加β受体阻滞剂)的疗效。
在术后第一个月,60例患者出院后房颤复发。胺碘酮治疗组和对照组的事件发生率无差异(47%对50%,p=无统计学意义),而单独使用β受体阻滞剂或与胺碘酮联用的患者发生率显著较低(分别为10%和9%,p=0.002)。随访结束时(10±5个月),176例研究患者中有3例房颤持续存在(1.7%)。
在接受心脏手术的患者中,出院后房颤复发在术后第一个月很常见且具有临床相关性。β受体阻滞剂(而非胺碘酮)似乎是一种有效的预防措施。这种现象在长期来看趋于消失,无需进行长期预防。